Rola chemioterapii neoadiuwantowej w leczeniu skojarzonym raka piersi

Abstract

Author(s): JACEK TOMCZYKOWSKI, KRZYSZTOF PATYRA

Neoadjuvant chemotherapy is a recognized means of combined treatment of locally advanced breast cancer, and in less advanced cases it can be used in the hope of allowing greater conservation of the breast. Modern neoadjuvant chemiotherapy programmes can lead to 31-65% of pathological complete response. A direct comparison of neoadjuvant chemotherapy with an identical adjuvant treatment has not pointed to a significant increase in overal survivall. It is hoped that neoadjuvant chemotherapy will be more widely used in treatment of breast cancer. A thorough assessment of tumor response to primary chemotherapy offers a practical possibility to optimise treatment, and maybe changes of concept in treatment in this kind of cancer.

Share this article

Editors List

  • S.SREEDHAR

    Submitted PhD thesis in Biotechnology at GITAM University, Vizag.

  • Yousef Alomi

    Yousef Alomi
    The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
    Saudi Arabia Critical Care/TPN
    Clinical Pharmacist Ministry of Health,
    Riyadh, Saudi Arabia.

  • Osamu Tanaka

    Osamu Tanaka
    Assistant Professor,
    Department of Radiation Oncology
    Asahi University Hospital
    Gifu city, Gifu, Japan

  • Maher Abdel Fattah Al-Shayeb

    Department of Surgical Sciences, Ajman University, UAE

  • Andrzej Zdziennicki

    Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)

Google Scholar citation report
Citations : 61

Onkologia i Radioterapia received 61 citations as per Google Scholar report

Flyer image
Onkologia i Radioterapia peer review process verified at publons
Flyer image
Indexed In
  • Scimago
  • SCOPUS
  • MIAR
  • Euro Pub
  • Google Scholar
  • Medical Project Poland
  • PUBMED
  • Cancer Index
  • Gdansk University of Technology, Ministry Points 20
View More